4.3 Frailty, Orthostatic Hypotension, and Age-Friendly Care Frameworks

Quick Overview: Heart failure predominantly affects older adults, in whom cardiovascular pathology frequently converges with multisystem biological aging. Chronological age alone is an unreliable indicator of functional vulnerability. The Certified Heart Failure Nurse (CHFN) must differentiate between chronological age, sarcopenia, cardiac cachexia, and clinical frailty. Frailty exponentially elevates the risk of guideline-directed medical therapy (GDMT) intolerance, falls, cognitive delirium, and 30-day rehospitalization. Systematically evaluating frailty through the Fried Frailty Phenotype, conducting formal orthostatic vital sign assessments with non-pharmacologic countermeasures to protect neurohormonal therapies, and embedding the Age-Friendly Health Systems '4Ms' Framework (What Matters, Medication, Mentation, Mobility) into routine nursing care ensures person-centered, evidence-based management of complex older adults.

---

Multidimensional Frailty: Biological Vulnerability vs. Chronological Age

Frailty is not an inevitable consequence of aging, nor is it synonymous with multimorbidity. Rather, frailty is a biological syndrome of decreased physiological reserve and diminished resistance to stressors, resulting from cumulative, multi-organ subclinical decline. When an acute minor stressor occurs (such as a mild urinary tract infection, medication adjustment, or warm summer weather), a robust individual recovers quickly, whereas a frail patient experiences catastrophic functional deterioration, delirium, falls, or acute decompensated heart failure.

                     THE SPECTRUM OF BODY COMPOSITION & WASTING IN HF
                     ────────────────────────────────────────────────
┌────────────────────┬────────────────────────────────────────────────────────────────────────┐
│ Entity             │ Pathophysiological Mechanism & Diagnostic Hallmarks                    │
├────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Chronological  │ The calendar passage of time; poor independent predictor of procedural │
│ Aging          │ success, LVAD survival, or medication tolerance.                       │
├────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Sarcopenia     │ Age-related loss of skeletal muscle mass and function without obligate │
│                    │ fat or bone loss. Reversible with progressive resistance exercise.     │
├────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Cardiac        │ Severe, involuntary, non-edematous weight loss of ≥ 5% of dry weight│
│ Cachexia       │ over 6–12 months. Driven by intense catabolic cytokine storms (TNF-α,  │
│                    │ IL-1, IL-6), neurohormonal activation, endotoxemia from gut congestion,│
│                    │ and lipolysis/muscle proteolysis. 18-month mortality ~50%.         │
├────────────────────┼────────────────────────────────────────────────────────────────────────┤
│ Biological     │ Multisystem physiological vulnerability across functional, physical,   │
│ Frailty        │ cognitive, and nutritional domains; measured by Fried Phenotype.       │
└────────────────────┴────────────────────────────────────────────────────────────────────────┘

The Fried Frailty Phenotype: Clinical Assessment Criteria

Developed by Dr. Linda Fried and colleagues, the Fried Frailty Phenotype is the most widely validated objective tool in cardiovascular medicine. It assesses five physical criteria:

1. Unintentional Weight Loss: Loss of ≥ 10 pounds (or ≥ 5% of body weight) unintentionally in the preceding 12 months.
2. Self-Reported Exhaustion: Identified using two statements from the Center for Epidemiological Studies Depression (CES-D) scale: "I felt that everything I did was an effort" or "I could not get going." Experiencing either feeling ≥ 3 days per week qualifies.
3. Low Physical Activity: Energy expenditure assessed via the Minnesota Leisure Time Physical Activity Questionnaire. Cutoff: lowest quintile of activity (< 383 kcal/week for men, < 270 kcal/week for women; equivalent to no regular exercise or walking).
4. Slowness (Slow Gait Speed): Measured via a timed 4-meter or 5-meter walking test at usual walking pace:
   • Cutoff: Gait speed ≤ 0.8 meters/second (or taking ≥ 5 seconds to traverse 4 meters).
   • Clinical Significance: Gait speed ≤ 0.8 m/s strongly predicts post-transplant mortality, surgical complications, and functional dependence.
5. Weakness (Low Grip Strength): Quantified using an isometric handheld hydraulic dynamometer across three maximal attempts on the dominant hand, stratified by sex and body mass index (BMI):
   • For example: Men with BMI ≤ 24 having grip strength ≤ 29 kg; women with BMI ≤ 23 having grip strength ≤ 17 kg.

Scoring and Clinical Classification:

• 0 Criteria Met: Robust (Non-frail)
• 1 to 2 Criteria Met: Prefrail (high risk of progressing to frail within 12–24 months; primary target for nurse-led exercise and nutritional prehabilitation)
• 3 to 5 Criteria Met: Clinically Frail (associated with a two- to threefold higher rate of 30-day all-cause readmission, elevated mortality, and high vulnerability to drug-induced hypotension)

---

Falls Risk Assessment and Prevention in Heart Failure

Older adults with heart failure fall more often than age-matched peers without heart failure. Falls in HF patients are particularly devastating: they result in traumatic intracranial hemorrhage (frequently fatal in anticoagulated patients with atrial fibrillation), hip fractures, prolonged immobilization, and permanent loss of independent living.

The Multifactorial Drivers of Falls in Heart Failure

• Hemodynamic & Autonomic Instability: Blunted baroreceptor sensitivity, low forward cardiac output, post-prandial splanchnic blood pooling, and orthostatic hypotension.
• Polypharmacy & Vasodilation: Concurrent administration of vasodilators (ARNIs, ACE inhibitors, hydralazine, nitrates), beta-blockers, and central sedatives.
• Diuretic-Induced Nocturia: Urgency and frequency at night force patients to ambulate rapidly through dark hallways while half-asleep, groggy, and volume-depleted.
• Sarcopenia & Sensory Deficits: Proximal lower extremity muscle atrophy, peripheral diabetic neuropathy, diminished proprioception, and impaired visual acuity.

Clinical Fall Risk Screening Algorithms

• CDC STEADI (Stopping Elderly Accidents, Deaths, & Injuries): Begins with three screening questions: "Have you fallen in the past year?", "Do you feel unsteady when standing or walking?", and "Do you worry about falling?" Answering "yes" to any question mandates objective mobility testing:
  • Timed Up and Go (TUG) Test: The patient rises from an armchair, walks 10 feet (3 meters) at normal pace, turns, walks back, and sits down. A time ≥ 12 seconds indicates elevated fall risk.
  • 30-Second Chair Stand Test: Assesses lower body strength; a below-average score for age and sex (STEADI norms) signals lower-body weakness and higher fall risk.
  • 4-Stage Balance Test: Evaluates static balance across parallel, semi-tandem, tandem, and single-leg stances.
• Morse Fall Scale: Evaluates six clinical variables (history of falls, secondary diagnoses, ambulatory aids, intravenous therapy/saline locks, gait/transferring, and mental status). Scores of 51 or more denote high fall risk on the original scale (many facilities use 45 or more) and require dedicated safety care plans.

Environmental Home Hazard Assessment

Over 50% of falls occur inside the patient's home. The CHFN educates patients and caregivers on an environmental safety checklist:

• Remove all throw rugs, scatter mats, and loose runner carpets (or secure edges with double-sided carpet tape).
• Install illuminated rocker switches and continuous motion-activated nightlights along the pathway from bed to bathroom.
• Install professionally bolted grab bars inside showers and beside toilets (suction-cup bars are strictly unsafe).
• Place non-skid rubber adhesive strips or rubber mats inside tubs and showers; provide a sturdy shower bench.
• Keep floors clear of clutter, low coffee tables, footstools, and exposed electrical or oxygen tubing.

---

Orthostatic Hypotension and Non-Pharmacologic Countermeasures

Orthostatic hypotension (OH) is documented in up to 40% of patients with chronic heart failure. It triggers dizziness, syncope, falls, and functional fear that causes patients to abandon daily ambulation.

Standardized Orthostatic Vital Sign Protocol

1. Place the patient in a supine position (or comfortable seated position if supine is clinically contraindicated due to orthopnea) for at least 5 minutes.
2. Measure resting baseline blood pressure (manual auscultation preferred) and pulse rate.
3. Assist the patient to a full standing position.
4. Measure blood pressure and pulse rate at 1 minute and again at 3 minutes of quiet standing. Inquire about symptoms of cerebral hypoperfusion (lightheadedness, dizziness, blurred vision, coat-hanger neck pain, presyncope).

                  ORTHOSTATIC BLOOD PRESSURE DIAGNOSTIC THRESHOLDS
                  ────────────────────────────────────────────────
       Baseline: Patient Supine for 5 minutes ──► Measure Baseline BP & HR
                                  │
                                  ▼
                 Patient Stands for 1 and 3 Minutes
                                  │
         ┌────────────────────────┴────────────────────────┐
         ▼                                                 ▼
[Systolic Drop ≥ 20 mmHg]                         [Diastolic Drop ≥ 10 mmHg]
           OR                                                OR
[Systolic Drop ≥ 30 mmHg in supine HTN]           [Symptomatic Drop in BP]
                                  │
                                  ▼
                   CONFIRMED ORTHOSTATIC HYPOTENSION

Differentiating Hypovolemia from Neurogenic Autonomic Failure

The heart rate response during orthostatic testing reveals the underlying pathophysiological mechanism:

Non-Pharmacologic Stepladder: Protecting GDMT

[!CAUTION] The GDMT Down-Titration Reflex: When an older adult reports mild orthostatic dizziness, clinicians frequently react by discontinuing or slashing beta-blockers or ARNIs. This is a hazardous mistake. Registry studies link GDMT down-titration or discontinuation with higher subsequent mortality and rehospitalization. Guideline-directed medical therapy must be protected by applying non-pharmacological countermeasures first!

1. Acute Water Bolus (Only If the Fluid Plan Allows): In autonomic failure, drinking about 400 to 500 mL of water can raise standing systolic pressure within 5 to 15 minutes for about an hour through a sympathetic pressor reflex. In heart failure this conflicts with any fluid restriction, so use it only with the heart failure clinician's approval and count it toward the daily fluid allowance.
2. Abdominal Binders & Waist-High Compression: The splanchnic venous circulation is the largest compliant venous reservoir in the human body, pooling up to 25% of total blood volume. An elastic abdominal binder (applying 15–20 mmHg pressure) compresses the splanchnic bed and prevents postural pooling far more effectively than knee-high stockings. Waist-high compression stockings (20 to 30 mmHg) provide additional lower extremity support.
3. Head-of-Bed Elevation (10 to 15 degrees / 6 inches): Sleeping completely flat promotes renal perfusion, suppressing nighttime RAAS and causing nocturnal pressure natriuresis (massive fluid loss overnight). Elevating the head of the bed preserves midnight intravascular volume and mitigates severe morning orthostatic drops.
4. Physical Counter-Maneuvers: Teach patients isometric skeletal muscle contractions before and during standing: crossing legs while standing, squatting, clenching buttocks, flexing abdominal muscles, and performing calf-muscle heel-toe raises. These actions mechanically compress veins, pumping pooled blood back to the right atrium.
5. Medication Timing Optimization: Administer vasodilating medications (e.g., sacubitril/valsartan or carvedilol) at bedtime or space them throughout the day rather than stacking them all in the morning when orthostasis is most pronounced.

---

The Age-Friendly "4Ms" Framework Integrated into Heart Failure

Developed by the Institute for Healthcare Improvement (IHI) and The John A. Hartford Foundation, the Age-Friendly Health Systems 4Ms Framework reorganizes clinical care around four essential, interdependent pillars of geriatric vitality.

                             THE AGE-FRIENDLY "4Ms" IN HEART FAILURE
                                                │
          ┌───────────────────┬─────────────────┴─────────────────┬───────────────────┐
          ▼                   ▼                                   ▼                   ▼
    WHAT MATTERS         MEDICATION                           MENTATION            MOBILITY
• Patient-defined   • Optimize 4 Pillars of GDMT        • Delirium screening • Maintain functional
  priorities and      at tolerated doses                  (CAM / 4AT)          independence
  life goals        • Deprescribe inappropriate drugs   • Depression screen  • Preserve safe
• Align interventions (AGS Beers Criteria: eliminate       (PHQ-2 / PHQ-9)      ambulation
  with values         NSAIDs, anticholinergics)         • Dementia / MoCA    • Cardiac rehab and
• Advance Care Plans• Mitigate cost & polypharmacy        screening for meds   fall prevention

1. What Matters

• Principle: Know and align the care plan with each older adult's specific health outcome goals and care preferences, including functional independence, cognitive clarity, and end-of-life wishes.
• Clinical Application: Heart failure visits should not focus solely on laboratory numbers and ejection fractions. Ask: "What is the most important thing you want to be able to do this month?" (e.g., attending a grandchild's wedding, remaining living independently in their home, avoiding hospitalizations). When invasive therapies (LVAD, ICD shocks) conflict with the patient's core values, advance care planning and POLST (Physician Orders for Life-Sustaining Treatment) directives are established early.

2. Medication

• Principle: If medications are necessary, prescribe age-friendly options that do not interfere with What Matters, Mentation, or Mobility.
• Clinical Application:
  • Optimize the 4 pillars of GDMT (ARNI, beta-blocker, MRA, SGLT2i) at individually tolerated doses, utilizing non-pharmacologic strategies to manage asymptomatic low blood pressure.
  • Apply the American Geriatrics Society (AGS) Beers Criteria to actively deprescribe harmful, inappropriate medications:
    • NSAIDs (ibuprofen, naproxen, meloxicam): Trigger renal vasoconstriction, blunt loop diuretic response, cause severe sodium/water retention, and double heart failure hospitalization rates.
    • Non-dihydropyridine Calcium Channel Blockers (verapamil, diltiazem): Potent negative inotropes; strictly contraindicated in HFrEF.
    • First-Generation Antihistamines & Anticholinergics (diphenhydramine, hydroxyzine): Exacerbate cognitive decline, precipitate acute urinary retention, and increase fall risk.
    • Tricyclic Antidepressants & Muscle Relaxants: Induce orthostatic hypotension and malignant cardiac conduction delays.

3. Mentation

• Principle: Prevent, identify, treat, and manage dementia, depression, and delirium across care settings.
• Clinical Application:
  • Delirium: Assess for fluctuating attention and acute encephalopathy using the Confusion Assessment Method (CAM) or 4AT. Up to 30% of hospitalized older adults with heart failure develop delirium, often triggered by severe cerebral hypoperfusion, aggressive diuresis, electrolyte disturbances, or sleep disruption.
  • Depression: Screen routinely with the Patient Health Questionnaire (PHQ-2 and PHQ-9). Depression affects 20% to 40% of heart failure patients and independently doubles mortality by causing self-care apathy and poor medical adherence.
  • Cognitive Impairment / Dementia: Screen using validated rapid tools such as the Mini-Cog (three-item word recall and clock-drawing test) or Montreal Cognitive Assessment (MoCA). Cognitive deficits impair the patient's ability to follow fluid restrictions, interpret daily weight fluctuations, and manage complex multidrug regimens. Nurses must simplify dosing schedules, organize pillboxes, and engage designated family surrogates.

4. Mobility

• Principle: Ensure that older adults move safely every day to maintain function and support What Matters.
• Clinical Application:
  • Prescribe safe, home-based or center-based Phase II Cardiac Rehabilitation and progressive walking programs.
  • Encourage resistance bands to counter sarcopenia.
  • Eliminate unnecessary bedrest during hospital stays by establishing early ambulation orders.
  • Refer to physical therapy for assistive device fitting (four-wheeled rolling walker with handbrakes) to ensure stability and reduce fall-related fear.

---

Clinical Case Scenario: Navigating Orthostasis and Frailty

An 81-year-old male with chronic HFrEF (LVEF 30%), stage 3 chronic kidney disease (baseline creatinine 1.3 mg/dL), and diabetic neuropathy presents to the outpatient heart failure clinic accompanied by his daughter. The daughter reports that her father has become increasingly "shaky and unsteady on his feet" and nearly collapsed when getting out of bed yesterday morning.

• Current Medications: Sacubitril/valsartan 49/51 mg BID, carvedilol 12.5 mg BID, spironolactone 25 mg daily, empagliflozin 10 mg daily, furosemide 40 mg daily in the morning, and over-the-counter diphenhydramine 25 mg at bedtime for insomnia.
• Physical Examination: Patient appears thin and frail. Lungs are completely clear. Jugular venous pressure is estimated at < 2 cm above the sternal angle (flat neck veins). Mucous membranes are dry. Trace pretibial edema is noted.
• Orthostatic Vital Signs:
  • Supine (after 5 minutes): BP 118/74 mmHg, HR 68 bpm.
  • Standing (at 3 minutes): BP 92/56 mmHg (drop of 26/18 mmHg), HR 71 bpm (increase of only 3 bpm).
  • The patient complains of feeling dizzy and "woozy" during standing.
• Laboratory Profile: Serum creatinine has risen to 1.8 mg/dL (baseline 1.3 mg/dL), BUN is 42 mg/dL (BUN/Cr ratio 23:1), serum potassium is 4.6 mEq/L.

Clinical Analysis & Expert Nursing Interventions:

1. Diagnosing the Mechanism: The patient has severe orthostatic hypotension. The heart rate increased by only 3 bpm despite a 26 mmHg drop in systolic pressure, indicating blunted autonomic baroreflex function from diabetic neuropathy. However, his flat neck veins, dry oral mucosa, acute creatinine rise, and BUN/Cr ratio > 20:1 confirm superimposed intravascular hypovolemia from excessive diuretic therapy.
2. Immediate Medication Optimization (Protecting GDMT):
   • Rather than stopping the life-saving ARNI or beta-blocker, the nurse advocates to temporarily withhold or reduce furosemide to 20 mg every other day, as the patient has zero pulmonary congestion and flat neck veins.
   • Using the AGS Beers Criteria, the nurse instructs the patient to discontinue over-the-counter diphenhydramine, which contributes to daytime anticholinergic dizziness, cognitive fog, and increased fall risk.
3. Non-Pharmacologic Countermeasures:
   • The nurse fits the patient with an elastic abdominal binder and, after confirming with the heart failure clinician that he has no fluid restriction, suggests a glass of water before rising in the morning.
   • Instructs the family to elevate the head of the patient's bed by 6 inches (10 degrees).
   • Teaches the daughter and patient physical counter-maneuvers (isometric leg and buttock clenching before standing).
4. Age-Friendly 4Ms Integration:
   • Mobility: Administers the STEADI TUG test (score 15 seconds; high fall risk) and submits a home physical therapy referral for balance training and a rolling walker evaluation.
   • Mentation: Administers the Mini-Cog (normal word recall; clock drawing slightly distorted), prompting a pillbox organizer setup with the daughter.
5. Follow-Up Outcome: One week later, repeat clinic evaluation reveals standing BP has improved to 108/66 mmHg without dizziness, serum creatinine has improved to 1.4 mg/dL, and the patient successfully remains on full quadruple GDMT without further near-falls.

---

CHFN Exam Traps & Clinical Pearls

[!WARNING] Exam Trap: Reflexively Stopping GDMT for Low Blood Pressure. Do not fall into the trap of discontinuing mortality-reducing neurohormonal blockers at the first mention of orthostatic symptoms. Always evaluate volume status first! If the patient is over-diuresed (dry mucous membranes, flat neck veins, elevated BUN/Cr ratio), the correct first step is to reduce the loop diuretic dose, not the beta-blocker or ARNI. Simultaneously implement non-pharmacologic countermeasures (abdominal binders, counter-maneuvers, and a water bolus only if the fluid plan allows).

[!IMPORTANT] Clinical Pearl: Blunted Heart Rate in Autonomic Failure. Remember the rule of thumb during orthostatic vital sign testing: if standing blood pressure plunges by ≥ 20 mmHg and the heart rate jumps by > 15-20 bpm, think hypovolemia/dehydration. If the blood pressure plunges and the heart rate barely budges (< 10 bpm rise), think neurogenic autonomic failure / baroreceptor desensitization.

[!TIP] Exam Trap: Beers Criteria Antihistamines and NSAIDs. Any question describing an older heart failure patient taking over-the-counter sleep aids (diphenhydramine) or arthritis relievers (ibuprofen, naproxen) should immediately trigger alarm bells. NSAIDs blunt diuretics, cause acute renal decompensation, and induce sodium retention; diphenhydramine triggers delirium and falls. Both are high-priority deprescribing targets on the CHFN exam.